4DMedical Limited
FDMDF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 91.9% | 324.4% | -31.8% | – |
| Gross Profit | $0 | $0 | -$0 | $0 |
| % Margin | 92.1% | 92.2% | -3,378.6% | 26.6% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -786.7% | -1,044.6% | -6,099.9% | -3,343.9% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -513.7% | -1,179.8% | -4,378% | -2,332.6% |
| EPS Diluted | -0.14 | -0.097 | -0.1 | -0.084 |
| % Growth | -44.2% | 2.9% | -19.8% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |